Cargando…

Amino Functionalized Micro-Mesoporous Hybrid Particles for the Sustained Release of the Antiretroviral Drug Tenofovir

The sustained release of an antiretroviral agent to women mucosa has been proved as an excellent strategy to reduce the sexual transmission of HIV. Hybrid micro-mesoporous particles have been synthesized and functionalized with a silane coupling agent followed by loading the antiretroviral tenofovir...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin-Illana, Araceli, Cazorla-Luna, Raul, Notario-Pérez, Fernando, Ruiz-Caro, Roberto, Bedoya, Luis Miguel, Veiga-Ochoa, Maria Dolores, Rubio, Juan, Tamayo, Aitana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476006/
https://www.ncbi.nlm.nih.gov/pubmed/32784712
http://dx.doi.org/10.3390/ma13163494
_version_ 1783579634963578880
author Martin-Illana, Araceli
Cazorla-Luna, Raul
Notario-Pérez, Fernando
Ruiz-Caro, Roberto
Bedoya, Luis Miguel
Veiga-Ochoa, Maria Dolores
Rubio, Juan
Tamayo, Aitana
author_facet Martin-Illana, Araceli
Cazorla-Luna, Raul
Notario-Pérez, Fernando
Ruiz-Caro, Roberto
Bedoya, Luis Miguel
Veiga-Ochoa, Maria Dolores
Rubio, Juan
Tamayo, Aitana
author_sort Martin-Illana, Araceli
collection PubMed
description The sustained release of an antiretroviral agent to women mucosa has been proved as an excellent strategy to reduce the sexual transmission of HIV. Hybrid micro-mesoporous particles have been synthesized and functionalized with a silane coupling agent followed by loading the antiretroviral tenofovir. It has been observed that the disposition of the silane molecule on the surface of the particles determines the interaction mechanism with the antiretroviral molecule loaded independently on the surface area of the particles. In this sense, available and free amino groups are required to achieve a smart pH-responsive material, a condition that is only achieved in those materials containing a silane chemisorbed monolayer. Moreover, the modulation of the release kinetics attributed to the presence of the silane monolayer covering the mesopores has been confirmed by fitting the releasing curves to the first order and Weibull models. The developed micro-mesoporous particles have been demonstrated to be excellent smart-release vehicles for antiviral agents and can be safely used in polymer mucoadhesive vaginal gels.
format Online
Article
Text
id pubmed-7476006
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74760062020-09-09 Amino Functionalized Micro-Mesoporous Hybrid Particles for the Sustained Release of the Antiretroviral Drug Tenofovir Martin-Illana, Araceli Cazorla-Luna, Raul Notario-Pérez, Fernando Ruiz-Caro, Roberto Bedoya, Luis Miguel Veiga-Ochoa, Maria Dolores Rubio, Juan Tamayo, Aitana Materials (Basel) Article The sustained release of an antiretroviral agent to women mucosa has been proved as an excellent strategy to reduce the sexual transmission of HIV. Hybrid micro-mesoporous particles have been synthesized and functionalized with a silane coupling agent followed by loading the antiretroviral tenofovir. It has been observed that the disposition of the silane molecule on the surface of the particles determines the interaction mechanism with the antiretroviral molecule loaded independently on the surface area of the particles. In this sense, available and free amino groups are required to achieve a smart pH-responsive material, a condition that is only achieved in those materials containing a silane chemisorbed monolayer. Moreover, the modulation of the release kinetics attributed to the presence of the silane monolayer covering the mesopores has been confirmed by fitting the releasing curves to the first order and Weibull models. The developed micro-mesoporous particles have been demonstrated to be excellent smart-release vehicles for antiviral agents and can be safely used in polymer mucoadhesive vaginal gels. MDPI 2020-08-07 /pmc/articles/PMC7476006/ /pubmed/32784712 http://dx.doi.org/10.3390/ma13163494 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Martin-Illana, Araceli
Cazorla-Luna, Raul
Notario-Pérez, Fernando
Ruiz-Caro, Roberto
Bedoya, Luis Miguel
Veiga-Ochoa, Maria Dolores
Rubio, Juan
Tamayo, Aitana
Amino Functionalized Micro-Mesoporous Hybrid Particles for the Sustained Release of the Antiretroviral Drug Tenofovir
title Amino Functionalized Micro-Mesoporous Hybrid Particles for the Sustained Release of the Antiretroviral Drug Tenofovir
title_full Amino Functionalized Micro-Mesoporous Hybrid Particles for the Sustained Release of the Antiretroviral Drug Tenofovir
title_fullStr Amino Functionalized Micro-Mesoporous Hybrid Particles for the Sustained Release of the Antiretroviral Drug Tenofovir
title_full_unstemmed Amino Functionalized Micro-Mesoporous Hybrid Particles for the Sustained Release of the Antiretroviral Drug Tenofovir
title_short Amino Functionalized Micro-Mesoporous Hybrid Particles for the Sustained Release of the Antiretroviral Drug Tenofovir
title_sort amino functionalized micro-mesoporous hybrid particles for the sustained release of the antiretroviral drug tenofovir
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476006/
https://www.ncbi.nlm.nih.gov/pubmed/32784712
http://dx.doi.org/10.3390/ma13163494
work_keys_str_mv AT martinillanaaraceli aminofunctionalizedmicromesoporoushybridparticlesforthesustainedreleaseoftheantiretroviraldrugtenofovir
AT cazorlalunaraul aminofunctionalizedmicromesoporoushybridparticlesforthesustainedreleaseoftheantiretroviraldrugtenofovir
AT notarioperezfernando aminofunctionalizedmicromesoporoushybridparticlesforthesustainedreleaseoftheantiretroviraldrugtenofovir
AT ruizcaroroberto aminofunctionalizedmicromesoporoushybridparticlesforthesustainedreleaseoftheantiretroviraldrugtenofovir
AT bedoyaluismiguel aminofunctionalizedmicromesoporoushybridparticlesforthesustainedreleaseoftheantiretroviraldrugtenofovir
AT veigaochoamariadolores aminofunctionalizedmicromesoporoushybridparticlesforthesustainedreleaseoftheantiretroviraldrugtenofovir
AT rubiojuan aminofunctionalizedmicromesoporoushybridparticlesforthesustainedreleaseoftheantiretroviraldrugtenofovir
AT tamayoaitana aminofunctionalizedmicromesoporoushybridparticlesforthesustainedreleaseoftheantiretroviraldrugtenofovir